Zacks Investment Research on MSN11h
Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag
Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of ...
Pharmaceutical Technology on MSN15h
FDA fast tracks Sanofi’s mRNA vaccine for chlamydia
Sanofi will soon commence a Phase I/II trial with its vaccine candidate to start generating immunogenicity data.
Analysts Set Sanofi (NASDAQ:SNY) PT at $60.00
Sanofi (NASDAQ:SNY – Get Free Report) has been assigned an average recommendation of “Buy” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. Two research ...
Sanofi Chlamydia vaccine candidate granted fast track designation by the US FDA
Chlamydia vaccine candidate granted fast track designation by the US FDA Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or infer ...